Clarivate (16A) Q2 2026 Earnings Report

The call emphasized clear progress on strategic priorities—AI product launches with early commercial traction, margin expansion, debt reduction and a higher-quality recurring revenue mix driven by portfolio rationalization. These positives were tempered by near-term headwinds including a large non-cash impairment related to the LS&H divestiture, transactional revenue declines, one-time transaction costs that depress free cash flow this year, and FX impacts. Management presented a credible path to sequential organic growth and profitability improvement in the second half, with stronger recurring revenue mix and disciplined capital allocation supporting confidence in longer-term execution.

Management reaffirmed full‑year guidance but refined its outlook to reflect the planned LS&H divestiture: organic ACV is expected in the lower half of the range with recurring organic growth about 1.5% at the midpoint (A&G approaching ~3% and IP returning to growth by year‑end to blend to ~2.25%); full‑year revenue is now expected just below midpoint at $2.35 billion, adjusted EBITDA just over $1.0 billion (implying ~43% margin and ~200 bps of margin expansion year‑over‑year), adjusted diluted EPS about $0.75 (≈9% growth), and free cash flow at the low end of the range largely due to nearly $70 million of one‑time divestiture costs — yet management still expects to reduce debt by roughly $900 million this year; other guideposts include a pro forma recurring revenue mix of ~92%, $25 million of cost‑efficiency driven profit improvement, inorganic disposals lowering revenue by about $125 million while cutting operating expense by ~$100 million, a ~$20 million improvement in cash interest, $5–10 million higher cash taxes, a ~$25 million working‑capital use, a $10 million benefit from lower impaired contractual costs, and about $20 million lower capex.